Caitlin John LLC raised its holdings in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 51.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,679 shares of the specialty chemicals company's stock after buying an additional 2,255 shares during the quarter. Caitlin John LLC's holdings in Hawkins were worth $949,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in HWKN. Brooklyn Investment Group boosted its holdings in shares of Hawkins by 533.3% in the 1st quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 224 shares in the last quarter. Vermillion Wealth Management Inc. purchased a new position in shares of Hawkins in the 4th quarter worth about $34,000. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Hawkins by 118.8% in the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company's stock worth $30,000 after purchasing an additional 152 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in shares of Hawkins in the 1st quarter worth about $42,000. Finally, Russell Investments Group Ltd. purchased a new position in shares of Hawkins in the 1st quarter worth about $52,000. 69.71% of the stock is currently owned by hedge funds and other institutional investors.
Hawkins Trading Down 0.9%
HWKN traded down $1.57 during midday trading on Monday, reaching $172.17. 112,238 shares of the company's stock traded hands, compared to its average volume of 146,868. The firm has a fifty day moving average of $168.77 and a two-hundred day moving average of $140.37. The stock has a market capitalization of $3.59 billion, a price-to-earnings ratio of 42.41, a P/E/G ratio of 2.46 and a beta of 0.86. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.31 and a quick ratio of 1.45. Hawkins, Inc. has a 52 week low of $98.30 and a 52 week high of $185.50.
Hawkins (NASDAQ:HWKN - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The specialty chemicals company reported $1.40 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.07. Hawkins had a return on equity of 18.35% and a net margin of 8.37%.The business had revenue of $293.27 million during the quarter, compared to analyst estimates of $278.76 million. On average, equities analysts anticipate that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.
Hawkins Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Friday, August 15th. This is an increase from Hawkins's previous quarterly dividend of $0.18. Hawkins's dividend payout ratio (DPR) is currently 18.72%.
Analysts Set New Price Targets
A number of research firms have recently issued reports on HWKN. Raymond James Financial began coverage on Hawkins in a report on Thursday, July 24th. They issued a "market perform" rating for the company. Zacks Research raised Hawkins to a "strong-buy" rating in a research note on Tuesday, August 12th. Wall Street Zen lowered Hawkins from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. Finally, BWS Financial boosted their target price on Hawkins from $160.00 to $200.00 and gave the company a "buy" rating in a research note on Friday, August 1st. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average target price of $162.50.
Get Our Latest Research Report on Hawkins
Hawkins Company Profile
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
See Also

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.